R. Bies

Estimation of Solid Tumor Doubling Times from Progression-Free Survival Plots Using a Novel Statistical Approach

R. Bies, D. Shah, K. Kay, 2019, The AAPS Journal.

Methadone: A Substrate and Mechanism-Based Inhibitor of CYP19 (Aromatase)

D. Flockhart, Wenjie Lu, Z. Desta, 2010, Drug Metabolism and Disposition.

Systemic exposure to hydroxychloroquine and its relationship with outcome in severely ill COVID‐19 patients in New York City

S. Cremers, Alex K Lyashchenko, D. McMahon, 2022, British journal of clinical pharmacology.

Mechanistic modeling of ophthalmic, nasal, injectable, and implant generic drug products: A workshop summary report

A. Babiskin, R. Walenga, D. Kozak, 2023, CPT: pharmacometrics & systems pharmacology.

Development of a genetic algorithm and NONMEM workbench for automating and improving population pharmacokinetic/pharmacodynamic model selection

Sihang Liu, Yifan Yu, Mark E. Sale, 2021, Journal of Pharmacokinetics and Pharmacodynamics.

Uridine glucuronosyltransferase 2B7 pharmacogenetics predicts epirubicin clearance and myelosuppression.

J. Mackey, M. Sawyer, E. Pituskin, 2009, Journal of Clinical Oncology.

A phase I/II study of nintedanib and capecitabine for refractory metastatic colorectal cancer

J. Ebos, M. Mastri, C. Fountzilas, 2024, JNCI cancer spectrum.